Navigation Links
MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference
Date:12/21/2011

NEW YORK, Dec. 21, 2011 /PRNewswire/ -- MedTRACK, an Informa business unit, and the world's leading provider of pharmaceutical-focused business intelligence, has recently unveiled a premier partnering tool for the J.P. Morgan Healthcare Conference. The partnering filter helps delegates attending the conference find licensing, investment and acquisition opportunities.

With the new MedTRACK Partnering Filter companies can quickly identify like-minded suitors in terms of product development sorted by therapy area, stage of development, mechanism of action and a host of additional search parameters. The partnering filter drastically reduces time spent on initial screening and can quickly identify the companies that are best suited for partner discussions or investment opportunities.

As part of the product roll out MedTRACK is offering conference delegates an opportunity to test drive the partner tool to see first-hand the value MedTRACK Partnering Filter can add to their business development discussions.

About J.P. Morgan Healthcare Conference
The J.P. Morgan 30th Annual Healthcare Conference will be held from January 9th to January 12th 2012 in San Francisco, CA. The four day conference features presentations from several hundred companies both private and public.

About MedTRACK
MedTRACK is the leader in commercial and scientific intelligence for the life-science industry. MedTRACK combines a multitude of datasets into a single, integrated platform that allows clients to quickly search and analyze data. With MedTRACK, you will spend less time looking for information, and more time supporting the strategic decisions that are critical to your business. To find out more about MedTRACK go to www.medtrack.com 

To find out more about MedTRACK and how you can leverage the J.P.Morgan filter call (570) 687-9318 in the U.S, or +44 (0) 20 7551 9622 internationally.

For further information, call:
US: (570) 687-9312
Europe: +44 (0) 20 7551 9622
Asia-Pacific: +61 2 8705 6900
Japan: +81 3 5148 7670


'/>"/>
SOURCE MedTRACK
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011
2. Touch Bionics unveils innovative partner and reimbursement programs at AOPA
3. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
4. FBI unveils science of anthrax investigation
5. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
6. McMaster University unveils worlds most advanced microscope
7. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
8. Video: Insulet Unveils Video Contest for OmniPod Users
9. FBI unveils science of anthrax investigation
10. DuPont Unveils New Strategy to Expand its Seed Business
11. Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):